Related references
Note: Only part of the references are listed.Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Postoperative Mortality in Cancer Patients With Preexisting Diabetes Systematic review and meta-analysis
Bethany B. Barone et al.
DIABETES CARE (2010)
Diabetes, prediabetes and cancer mortality
X. H. Zhou et al.
DIABETOLOGIA (2010)
Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
Kelly B. Stein et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase
L. Zeng et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
Leigh A. Cantrell et al.
GYNECOLOGIC ONCOLOGY (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Risk of Cancer Following Hospitalization for Type 2 Diabetes
Kari Hemminki et al.
ONCOLOGIST (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Bariatric surgery, weight reduction, and cancer prevention
Andrew G. Renehan
LANCET ONCOLOGY (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
Rosiglitazone and risk of cancer - A meta-analysis of randomized clinical trials
Matteo Monami et al.
DIABETES CARE (2008)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Paola Pisani
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
The impact of diabetes on survival following breast cancer
Lorraine L. Lipscombe et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The association of elevated HbA1c on the behavior of adenomatous polyps in patients with Type-II diabetes mellitus
Ali A. Siddiqui et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes
Ahmad Haidar et al.
AGING MALE (2007)
Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-retated mortality
M. Monami et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study
N. Travier et al.
ANNALS OF ONCOLOGY (2007)
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
Maria E. Ramos-Nino et al.
BMC MEDICINE (2007)
Prospective study of hyperglycemia and cancer risk
Par Stattin et al.
DIABETES CARE (2007)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Diabetes mellitus and the risk of cancer - Results from a large-scale population-based cohort study in Japan
Manami Inoue et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adult weight change and risk of postmenopausal breast cancer
AH Eliassen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada
MC Rousseau et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
AJ Swerdlow et al.
BRITISH JOURNAL OF CANCER (2005)
Type 2 diabetes: principles of pathogenesis and therapy
M Stumvoll et al.
LANCET (2005)
Serum levels of leptin, insulin, and lipids in relation to breast cancer in China
CZ Han et al.
ENDOCRINE (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Adiponectin and breast cancer risk
C Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
JM Lizcano et al.
EMBO JOURNAL (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
Cancer incidence in patients with type 1 diabetes mellitus:: A population-based cohort study in Sweden
K Zendehdel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Leptin levels in type 2 diabetes: Associations with measures of insulin resistance and insulin secretion
M Wauters et al.
HORMONE AND METABOLIC RESEARCH (2003)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
AM Wallace et al.
CIRCULATION (2001)
Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells
K Ohta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue
PG McTernan et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)